1d
Fintel on MSNCanaccord Genuity Initiates Coverage of Palvella Therapeutics (PVLA) with Buy RecommendationFintel reports that on February 20, 2025, Canaccord Genuity initiated coverage of Palvella Therapeutics (NasdaqCM:PVLA) with ...
2d
Hosted on MSNCanaccord Genuity Initiates Coverage of Candel Therapeutics (CADL) with Buy RecommendationFintel reports that on February 19, 2025, Canaccord Genuity initiated coverage of Candel Therapeutics (NasdaqGM:CADL) with a ...
Canaccord Genuity analyst Alexander Bedwany maintained a Buy rating on Taseko Mines (TGB – Research Report) today and set a price target of ...
Canaccord Genuity has downgraded Pliant (PLRX) to hold following news that the company has paused a clinical trial for its ...
SharkNinja (NYSE:SN – Free Report) had its price target increased by Canaccord Genuity Group from $129.00 to $136.00 in a ...
Canaccord Genuity analyst Paul Buys maintained a Hold rating on HUB24 Limited (FSB – Research Report) yesterday and set a price target of ...
PITTSBURGH, February 12, 2025--(BUSINESS WIRE)--Aurora Innovation, Inc. (NASDAQ: AUR) today announced David Maday, Chief ...
CyberArk Software (NASDAQ:CYBR – Get Free Report) had its target price hoisted by equities research analysts at Canaccord ...
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results